Opendata, web and dolomites

INVADERS SIGNED

Mucus-Penetrating Microbiota: Characterization, Mechanism and Therapeutic in Metabolic Disease

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 INVADERS project word cloud

Explore the words cloud of the INVADERS project. It provides you a very rough idea of what is the project "INVADERS" about.

protect    overwhelm    obesity    threatens    cell    diverse    clinical    benefits    inter    central    counteract    ultimately    inflammation    promotion    dire    epidemic    hypothesis    hyperglycemia    invaders    metabolic    ing    collectively    epithelial    host    altogether    public    characterization    appropriately    community    layer    provides    penetrating    preclinical    emulsifiers    food    mechanism    encroachment    cardiovascular    distance    diseases    reported    hyperlipidemia    ubiquitous    abnormalities    costly    class    disease    detrimentally    modulate    promoted    alter    additives    chronic    disturbance    models    stably    penetrate    inhabited    homeostasis    steatosis    inflammatory    microbiota    morbid    grade    genetic    herein    bacteria    insulin    therapeutic    tract    health    inner    monolayer    hepatic    incidence    resistance    mechanisms    drive    intestinal    mucus    original    investigation    world    safe    disorders    care    maintained    relationship    economies    alterations    previously    humanity    downstream   

Project "INVADERS" data sheet

The following table provides information about the project.

Coordinator
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE 

Organization address
address: RUE DE TOLBIAC 101
city: PARIS
postcode: 75654
website: www.inserm.fr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 1˙850˙000 €
 EC max contribution 1˙850˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-STG
 Funding Scheme ERC-STG
 Starting year 2019
 Duration (year-month-day) from 2019-10-01   to  2024-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FR (PARIS) coordinator 1˙850˙000.00

Map

 Project objective

Mucus-Penetrating Microbiota: Characterization, Mechanism and Therapeutic in Metabolic Disease

Humanity is facing an epidemic of inter-related metabolic disorders, including obesity, insulin resistance, hyperglycemia, hyperlipidemia, and hepatic steatosis, that altogether have major impact on the promotion of cardiovascular diseases. The increasing incidence of these complex metabolic disorders and their highly morbid, chronic and costly downstream diseases threatens to overwhelm the world’s health care systems and economies, making it a top public health priority in dire need of investigation. The intestinal tract is inhabited by a large and diverse community of bacteria, collectively referred to as the intestinal microbiota. When stably maintained at an appropriately safe distance from the epithelial cell monolayer, the microbiota provides important benefits to its host. However, disturbance of the microbiota-host relationship, promoted by genetic or non-genetic factors, can alter intestinal homeostasis and drive chronic low-grade intestinal inflammation, ultimately leading to metabolic abnormalities. We previously reported that a ubiquitous class of food additives, emulsifiers, detrimentally impact the microbiota resulting in its encroachment into the mucus layer that associated with low-grade inflammation and development of metabolic disorders. The central goal of this proposal is to investigate the hypothesis that bacteria that penetrate the inner part of the mucus layer, referred as invaders, promote development of metabolic alterations. We herein propose to identify mucus-invaders, in preclinical models and clinical conditions, and investigate mechanisms by which they promote inflammatory and metabolic abnormalities. Furthermore, we propose to define original approaches to modulate the intestinal microbiota in order to counteract microbiota encroachment and protect against associated metabolic abnormalities.

 Publications

year authors and title journal last update
List of publications.
2019 Hao Q. Tran, Ruth E. Ley, Andrew T. Gewirtz, Benoit Chassaing
Flagellin-elicited adaptive immunity suppresses flagellated microbiota and vaccinates against chronic inflammatory diseases
published pages: , ISSN: 2041-1723, DOI: 10.1038/s41467-019-13538-y
Nature Communications 10/1 2020-02-05

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "INVADERS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "INVADERS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

evolSingleCellGRN (2019)

Constraint, Adaptation, and Heterogeneity: Genomic and single-cell approaches to understanding the evolution of developmental gene regulatory networks

Read More  

IMMUNOTHROMBOSIS (2019)

Cross-talk between platelets and immunity - implications for host homeostasis and defense

Read More  

Andrea (2018)

A Novel Detection protocols for REliable prostate cancer Assays

Read More